Trial intelligence / Profile preview

Postoperative tranexamic acid to reduce blood loss after hip prosthesis surgery

2013-000791-15Phase 4Completed

Sponsor
CHU Saint-Etienne
Start
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of tranexamic acid in perioperative bleeding (2 arms), sponsored by CHU Saint-Etienne. Primary endpoint: Calculated perioperative blood loss (day 1 to day 5). Started Sep 2015; status: completed.

02

Drugs

tranexamic acid
03

Conditions

perioperative bleeding

Beyond the preview

Go deeper on 2013-000791-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-000791-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call